GATA3 expression is vastly utilized in the breast and the urothelial carcinomas due to its high specificity; and many other benign and malignant lesions arising from skin, kidney, uterus, testis, ovary, and pancreas [11]. Here, GATA3 is linked to urothelial carcinoma.